Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma
P. Sriskandarajah, A. K. de Haven Brandon, K. Macleod, N. Carragher, V. Kirkin, M. Kaiser, S. Whittaker
BMC Cancer